Abstract:Background Bacterial meningitis remains a big threat to the integrity of the central nervous system (CNS), despite the advancements in antimicrobial reagents. Escherichia coli is a bacterial pathogen that can disrupt the CNS function, especially in neonates. E. coli meningitis occurs after bacteria invade the brain microvascular endothelial cells (BMECs) that form a direct and essential barrier restricting the entry of circulating microbes and toxins to the brain. Previous studies have reported on several cellular proteins that function during meningitic E. coli infections; however, more comprehensive investigations to elucidate the potential targets involved in E. coli meningitis are essential to better understand this disease and discover new treatments for it. Methods The isobaric tags for relative and absolute quantification (iTRAQ) approach coupled with LC-MS/MS were applied to compare and characterize the different proteomic profiles of BMECs in response to meningitic or non-meningitic E. coli strains. KEGG and gene ontology annotations, ingenuity pathways analysis, and functional experiments were combined to identify the key host molecules involved in the meningitic E. coli -induced tight junction breakdown and neuroinflammatory responses. Results A total of 13 cellular proteins were found to be differentially expressed by meningitic E. coli strains PCN033 and RS218, including one that was also affected by HB101, a non-meningitic E. coli strain. Through bioinformatics analysis, we identified the macrophage migration inhibitory factor (MIF), granzyme A, NF-κB signaling, and mitogen-activated protein kinase (MAPK) pathways as being biologically involved in the meningitic E. coli -induced tight junction breakdown and neuroinflammation. Functionally, we showed that MIF facilitated meningitic E. coli -induced production of cytokines and chemokines and also helped to disrupt the blood-brain barrier by decreasing the expression of tight junction proteins like ZO-1, occludin. Moreover, we demonstrated the significant activation of NF-κB and MAPK signaling in BMECs in response to meningitic E. coli strains, which dominantly determined the generation of the proinflammatory cytokines including IL-6, IL-8, TNF-α, and IL-1β. Conclusions Our work identified 12 host cellular targets that are affected by meningitic E. coli strains and revealed MIF to be an important contributor to meningitic E. coli -induced cytokine production and tight junction disruption, and also the NF-κB and MAPK signaling pathways that are mainly involved in the infection-induced cytokines production. Characterization of these distinct proteins and pathways in BMECs will facilitate further elucidation of meningitis-causing mechanisms in humans and animals, thereby enabling the development of novel preventative and therapeutic strategies against infection with meningitic E. coli .

The transcriptome in patient cerebrospinal fluid identifies novel virulence factors required for meningitis

Group B Streptococcus transcriptome when interacting with brain endothelial cells

Peripheral blood vessels are a niche for blood-borne meningococci

Optimization of cerebrospinal fluid microbial DNA metagenomic sequencing diagnostics

High-throughput sequencing unravels the cell heterogeneity of cerebrospinal fluid in the bacterial meningitis of children

The CSF transcriptome in pneumococcal meningitis reveals compartmentalised host inflammatory responses associated with mortality.

Metagenomic Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Central Nervous System Infections: A Multicentre Cohort Study

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid

Employment of Broad Range 16S Rdna PCR and Sequencing in the Detection of Aetiological Agents of Meningitis.

High-throughput Sequencing of 16S Rdna Amplicons Characterizes Bacterial Composition in Cerebrospinal Fluid Samples from Patients with Purulent Meningitis.

The Primary Transcriptome of Neisseria Meningitidis and Its Interaction with the RNA Chaperone Hfq.

RNA-sequencing-based detection of human viral pathogens in cerebrospinal fluid and serum samples from children with meningitis and encephalitis

Next-Generation Sequencing Could be a Promising Diagnostic Approach for Pathogen Detection: Pathogenic Analysis of Pediatric Bacterial Meningitis by Next-Generation Sequencing Technology Directly from Cerebrospinal Fluid Specimens

Metagenomic next-generation sequencing of cell-free and whole-cell DNA in diagnosing central nervous system infections

Pathogen Identification in Culture-Negative Cerebrospinal Fluid Specimens of Patients with Purulent Meningitis Using Next-Generation Sequencing Technology.

Genomics and transcriptomics yields a system-level view of the biology of the pathogen Naegleria fowleri

Metagenomic next-generation sequencing of cerebrospinal fluid reveals etiological and microbiological features in patients with various central nervous system infections

Metagenomic next-generation sequencing of cerebrospinal fluid for diagnosis of central nervous system infections: 7-year performance of a clinically validated test

New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis

The Streptococcus Suis Transcriptional Landscape Reveals Adaptation Mechanisms in Pig Blood and Cerebrospinal Fluid

Molecular identification of Cryptococcus gattii from cerebrospinal fluid using single-cell sequencing: A case study